74 related articles for article (PubMed ID: 19064958)
1. Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate.
Hahn NM; Reckova M; Cheng L; Baldridge LA; Cummings OW; Sweeney CJ
J Clin Oncol; 2009 Jan; 27(3):460-3. PubMed ID: 19064958
[No Abstract] [Full Text] [Related]
2. Metastatic paraganglioma and treatment with sunitinib: a case report.
Cirillo F
Tumori; 2010; 96(6):1022-7. PubMed ID: 21388069
[TBL] [Abstract][Full Text] [Related]
3. Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.
Joshua AM; Ezzat S; Asa SL; Evans A; Broom R; Freeman M; Knox JJ
J Clin Endocrinol Metab; 2009 Jan; 94(1):5-9. PubMed ID: 19001511
[TBL] [Abstract][Full Text] [Related]
4. Sunitinib in the therapy of malignant paragangliomas: report on the efficacy in a SDHB mutation carrier and review of the literature.
Canu L; Pradella S; Rapizzi E; Fucci R; Valeri A; Briganti V; Giachè V; Parenti G; Ercolino T; Mannelli M
Arch Endocrinol Metab; 2017; 61(1):90-97. PubMed ID: 27737332
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib malate as the salvage therapy in advanced rectal carcinoid tumor.
Lu CC; Lin HF; Feng CC; Yu CY; Kao WY
Int J Colorectal Dis; 2008 Dec; 23(12):1265-6. PubMed ID: 18629516
[No Abstract] [Full Text] [Related]
6. F-18 FDG PET/CT assessment of gastrointestinal stromal tumor response to sunitinib malate therapy.
Banzo I; Quirce R; Martinez-Rodriguez I; Jimenez-Bonilla J; Sainz-Esteban A; Barragan J; Portilla-Quattrociocchi H; Carril JM
Clin Nucl Med; 2008 Mar; 33(3):211-2. PubMed ID: 18287850
[No Abstract] [Full Text] [Related]
7. Tumor response to sunitinib malate observed in clear-cell sarcoma.
Stacchiotti S; Grosso F; Negri T; Palassini E; Morosi C; Pilotti S; Gronchi A; Casali PG
Ann Oncol; 2010 May; 21(5):1130-1. PubMed ID: 20093352
[No Abstract] [Full Text] [Related]
8. Sarcomatoid non-small cell lung cancer responding to sunitinib.
Schultheis B; Kummer G; Strumberg D
Int J Clin Pharmacol Ther; 2013 Jan; 51(1):87-8. PubMed ID: 23260010
[No Abstract] [Full Text] [Related]
9. Sunitinib malate and multiple receptor tyrosine kinases inhibitors: are they also novel drugs for chronic and neurophatic pain?
Di Lorenzo L
J Clin Oncol; 2007 Jul; 25(19):2858-9; author reply 2859-61. PubMed ID: 17602094
[No Abstract] [Full Text] [Related]
10. Activity of sunitinib in patients with advanced neuroendocrine tumors.
Bajetta E; Guadalupi V; Procopio G
J Clin Oncol; 2009 Jan; 27(2):319-20; author reply 320. PubMed ID: 19064950
[No Abstract] [Full Text] [Related]
11. Sunitinib.
Heng DY; Kollmannsberger C
Recent Results Cancer Res; 2010; 184():71-82. PubMed ID: 20072832
[TBL] [Abstract][Full Text] [Related]
12. Sunitinib and the benefits of a negative study.
Forner A; Llovet JM; Bruix J
Lancet Oncol; 2009 Aug; 10(8):743-4. PubMed ID: 19647195
[No Abstract] [Full Text] [Related]
13. Sunitinib in renal-cell carcinoma: expanded indications.
Choueiri TK; Bellmunt J
Lancet Oncol; 2009 Aug; 10(8):740. PubMed ID: 19615941
[No Abstract] [Full Text] [Related]
14. Sunitinib therapy in renal cell carcinoma.
O'Brien MF; Russo P; Motzer RJ
BJU Int; 2008 Jun; 101(11):1339-42. PubMed ID: 18284408
[No Abstract] [Full Text] [Related]
15. Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.
Narayanan S; Callis-Duffin K; Batten J; Agarwal N
Am J Med Sci; 2010 Jun; 339(6):580-1. PubMed ID: 20421784
[TBL] [Abstract][Full Text] [Related]
16. Severe gastrointestinal hemorrhage due to metastatic renal cell carcinoma to the pancreas successfully controlled by transarterial embolization and adjuvant administration of Sunitinib Malate.
Akamatsu S; Kanamaru S; Takenawa J; Soeda A
Hinyokika Kiyo; 2008 Apr; 54(4):277-80. PubMed ID: 18516920
[TBL] [Abstract][Full Text] [Related]
17. Effect of sunitinib on renal cell carcinoma cutaneous metastasis.
Liu SW; Guitart JG; Kuzel TM; Gandhi M; Lacouture M
Int J Dermatol; 2009 Nov; 48(11):1269-70. PubMed ID: 20064194
[No Abstract] [Full Text] [Related]
18. Early development of sunitinib in hepatocellular carcinoma.
Zhu AX; Raymond E
Expert Rev Anticancer Ther; 2009 Jan; 9(1):143-50. PubMed ID: 19105714
[TBL] [Abstract][Full Text] [Related]
19. [Sunitinib for gastrointestinal stromal cell tumors and advanced renal cell carcinoma].
Vollmer H
Med Monatsschr Pharm; 2006 Oct; 29(10):386-7. PubMed ID: 17058904
[No Abstract] [Full Text] [Related]
20. Long-term response with sunitinib for metastatic renal cell carcinoma.
Ronnen EA; Kondagunta GV; Ginsberg MS; Russo P; Motzer RJ
Urology; 2006 Sep; 68(3):672.e19-20. PubMed ID: 16979716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
